BeOne Medicines (ONC) Change in Acquisitions & Divestments (2015 - 2025)

BeOne Medicines (ONC) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $1.6 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (up 29.79% YoY) and the FY2025 annual result came in at $3.4 million, up 29.79% from the prior year.
• Change in Acquisitions & Divestments fell to $1.6 million in Q4 2025 per ONC's latest filing, from $1.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $1.1 billion in Q1 2021 and bottomed at -$10000.0 in Q4 2021.
• The 5-year median for Change in Acquisitions & Divestments is $211.2 million (2022), against an average of $333.4 million.
• The widest annual swing landed in 2021, when Change in Acquisitions & Divestments plunged 100.0%; it then surged 2112300.0% in 2022.
• Tracing ONC's Change in Acquisitions & Divestments over 5 years: stood at -$10000.0 in 2021, then surged by 2112300.0% to $211.2 million in 2022, then plunged by 49.95% to $105.7 million in 2023, then slumped by 97.49% to $2.7 million in 2024, then plunged by 38.0% to $1.6 million in 2025.
• Per Business Quant, the three latest ONC Change in Acquisitions & Divestments figures stand at $1.6 million (Q4 2025), $1.8 million (Q1 2025), and $2.7 million (Q1 2024).

Peer Comparison